Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

被引：0
|
作者：
Wichard Vogel
Hans-Georg Kopp
Lothar Kanz
Hermann Einsele
机构：
[1] University of Tübingen,Department of Internal Medicine II, Division of Hematology, Oncology, Immunology and Rheumatology
来源：
Journal of Cancer Research and Clinical Oncology | 2005年 / 131卷
关键词：
Multiple myeloma; Peripheral autologous transplantation; Graft contamination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：214 / 218
页数：4
相关论文
共 50 条
  • [11] Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
    van Rhee, F.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (02): : 70 - 71
  • [12] Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
    Gulbrandsen, N
    Wisloff, F
    Brinch, L
    Carlson, K
    Dahl, IM
    Gimsing, P
    Hippe, E
    Hjorth, M
    Knudsen, LM
    Lamvik, J
    Lenhoff, S
    Lofvenberg, E
    Nesthus, I
    Nielsen, JL
    Turesson, L
    Westin, J
    MEDICAL ONCOLOGY, 2001, 18 (01) : 65 - 77
  • [13] Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
    N. Gulbrandsen
    F. Wisløff
    L. Brinch
    K. Carlson
    I. M. Dahl
    P. Gimsing
    E. Hippe
    M. Hjorth
    L. M. Knudsen
    J. Lamvik
    S. Lenhoff
    E. Løfvenberg
    I. Nesthus
    J. Lanng Nielsen
    I. Turesson
    J. Westin
    Medical Oncology, 2001, 18 : 65 - 77
  • [14] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
    Lisenko, Katharina
    Sauer, Sandra
    Bruckner, Thomas
    Egerer, Gerlinde
    Goldschmidt, Hartmut
    Hillengass, Jens
    Schmier, Johann W.
    Shah, Sofia
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Wuchter, Patrick
    BMC CANCER, 2017, 17
  • [15] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
    Katharina Lisenko
    Sandra Sauer
    Thomas Bruckner
    Gerlinde Egerer
    Hartmut Goldschmidt
    Jens Hillengass
    Johann W. Schmier
    Sofia Shah
    Mathias Witzens-Harig
    Anthony D. Ho
    Patrick Wuchter
    BMC Cancer, 17
  • [16] Randomized clinical trial of zoledronic acid in multiple myeloma patients undergoing high-dose chemotherapy and stem-cell transplantation
    Aviles, A.
    Neri, N.
    Huerta-Guzman, J.
    Nambo, M. J.
    CURRENT ONCOLOGY, 2013, 20 (01) : E13 - E20
  • [17] Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
    H. G. Kopp
    S. Yildirim
    K. C. Weisel
    L. Kanz
    W. Vogel
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 637 - 642
  • [18] Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
    Kopp, H. G.
    Yildirim, S.
    Weisel, K. C.
    Kanz, L.
    Vogel, W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (04) : 637 - 642
  • [19] Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma
    Yohay, Stephanie
    Oloyede, Temitope
    Kim, Soyoung
    Fang, Xi
    Dhakal, Binod
    Aijaz, Ayesha
    Mohan, Meera
    Narra, Ravi
    Pasquini, Marcelo
    D'Souza, Anita
    Hamadani, Mehdi
    Freeman, Ciara Louise
    Akhtar, Othman Salim
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2370 - 2375
  • [20] The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift?
    Kazandjian, Dickran
    Mo, Clifton C.
    Landgren, Ola
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) : 692 - 703
12345